Company profile for Enteris Biopharma Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Enteris BioPharma is a privately held, New Jersey-based biotech company offering innovative formulation solutions around our proprietary delivery technologies.The acquisition of clinically proven platform technologies from Unigene Laboratories, Inc. has positioned Enteris BioPharma as an industry leader in innovative oral dosage formulations. Our innovative formulation solutions enable the oral delivery of BCS class II, III an...
Enteris BioPharma is a privately held, New Jersey-based biotech company offering innovative formulation solutions around our proprietary delivery technologies.The acquisition of clinically proven platform technologies from Unigene Laboratories, Inc. has positioned Enteris BioPharma as an industry leader in innovative oral dosage formulations. Our innovative formulation solutions enable the oral delivery of BCS class II, III and IV compounds, including peptides, in an enteric-coated tablet. In addition to the industry leading oral delivery technology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
83 Fulton Street Boonton, NJ 07005
Telephone
Telephone
973-453-3518
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250715970521/en/Aptar-Pharma-Bolsters-Clinical-Trial-Capabilities-with-Strategic-Materials-Manufacturing-Acquisition

BUSINESSWIRE
15 Jul 2025

https://www.prnewswire.com/news-releases/enteris-biopharma-presents-study-of-ovarest-demonstrating-oral-delivery-comparable-to-or-exceeding-injectable-leuprolide-301659619.html

PRNEWSWIRE
26 Oct 2022

https://www.prnewswire.com/news-releases/swk-holdings-subsidiary-enteris-biopharma-receives-5-million-milestone-payment-from-cara-therapeutics-301644859.html

PRNEWSWIRE
10 Oct 2022

https://www.prnewswire.com/news-releases/enteris-biopharma-publishes-white-paper-examining-factors-to-consider-while-evaluating-oral-administration-of-peptides-301621732.html

PRNEWSWIRE
12 Sep 2022

https://www.prnewswire.com/news-releases/enteris-biopharma-manufacturing-expertise-highlighted-in-drug-development--delivery-special-feature-on-outsourcing-formulation-development--manufacturing-301598844.html

PRNEWSWIRE
03 Aug 2022

https://www.prnewswire.com/news-releases/enteris-biopharma-announces-acceptance-of-abstract-for-oral-presentation-at-asrm-2022-scientific-congress--expo-301586515.html

PRNEWSWIRE
14 Jul 2022

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

ABOUT THIS PAGE

Contact Enteris Biopharma Inc and get a quotation

Enteris Biopharma Inc is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of C-Peptide bulk offered by Enteris Biopharma Inc

Find a price of AMIDATING ENZYME bulk offered by Enteris Biopharma Inc

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty